Integra LifeSciences Holdings Corporation Announces Contract With Novation

PLAINSBORO, N.J., Sept. 24, 2008 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq:IART) announced today that Integra OrthoBiologics has signed a three-year contract with Novation, one of the industry’s leading contracting services companies, to supply Integra Mozaik(TM) Osteoconductive Scaffold, a novel collagen ceramic bone graft substitute product, to members of VHA, UHC and Provista. Integra OrthoBiologics is a world leader in high quality synthetic and human-derived bone graft material for use in both traditional and minimally invasive surgery, and was chosen for the quality, purity and value of its Integra Mozaik(TM) offering, and its outstanding customer service.

MORE ON THIS TOPIC